Stanford study offers hope for the hairless

Davis Chapman

03 August 2008

She and Dr Peter Marinkovich worked on a study about a molecule, called laminin-511, that triggers hair follicle expansion in mice and may do the same for humans.

Stanford analysts have highlighted a molecule that triggers hair follicle expansion in mice, care that one day could mean some shaggy dos, or at least a couple more strands, for humans who have experienced hair loss. The report, printed today in the Book of Genes and Development, concentrates on a molecule called laminin-511. The molecule acts like an operator, transferring messages, or proteins, between the outer and inner layers of skin, an exchange that at last drives hair formation. Unlike Rogaine or Propecia, products that slow hair loss, analysts hope the laminin-511 could possibly regenerate the tangible follicles that grow hair. "Loss of hair isn't going to murder anybody" related Dr Peter Marinkovich, the study's senior writer and an associate professor at Stanford College's Faculty of Medication . "At the same time, for some folks, hair loss could be an actually dire thing, particularly for women." he is hoping the treatment ultimately could help patients who suffer from alopecia, a disorder that may cause hair loss in patches, or speed up hair expansion for chemotherapy patients. Evidence implies laminin-511 could lead to above fuller heads of hair : Analysts assume the molecule may have the facility to regenerate other developing tissues, like limbs or perhaps organs ; but further tests are required to grasp precisely how that process works. The up to date study more obviously demonstrated the way in which the molecule transfers signals inside the skin in a way that especially excites follicle expansion. How shortly did scientists see results Mice injected with the purified molecule grew back hair in 2 weeks, at half of the thickness of an ordinary rodent. But if you are itching for a dose of laminin-511 to revive your once long locks, hold off on purchasing that bottle of hair gel : Do-It-Yourself treatments are likely years away.

The Stanford study presents a new understanding of how laminin-511 works, expounded Dr George Cotsarelis, director of the Hair and Scalp Hospital at the Varsity of Pennsylvania College of Drugs . But more clinical trials are required to show how humans will react to the treatment. Marinkovich claimed his group wants to repeat the tests on animals treated with chemotherapy and later on human subjects.